Increased IL-۱۷ and IL-۶ Transcripts in Peripheral Blood Mononuclear Cells: Implication for a Robust Proinflammatory Response in Early Stages of Breast Cancer
Publish place: Middle East Journal of Cancer، Vol: 2، Issue: 1
Publish Year: 1390
نوع سند: مقاله ژورنالی
زبان: English
View: 70
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MISJ-2-1_004
تاریخ نمایه سازی: 25 آبان 1402
Abstract:
Background: Several recent studies demonstrated that transforming growth factor beta (TGF-β), by stimulating T regulatory cells, and interleukins ۶ and ۱۷ (IL-۶, IL- ۱۷), by inducing inflammatory reactions, may be critical factors in cancer pathogenesis.Methods: We used quantitative real-time polymerase chain reaction assays to quantify the expression of IL-۱۷, IL-۶ and TGF-β mRNA in peripheral blood mononuclear cells and lymphocytes from draining lymph nodes of ۶۰ women with breast cancer. The results were compared according to the patients’ clinical or pathological status.Results: Higher amounts of IL-۱۷ and IL-۶ mRNA, but not TGF-β transcripts, were found in patients compared to controls. There were no significant differences between patients with negative or positive nodes or with different histological grades or stages of disease.Conclusion: Most women in this analysis had stage I or II disease. We thus conclude that IL-۱۷, a prominent proinflammatory cytokine, may play an important role in recruiting and infiltrating antitumor immune responses in early stages of breast cancer.
Authors
Mansooreh Jaberipour
Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
Rasoul Baharlou
Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
Ahmad Hosseini
Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
Abdolrasoul Talei
Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
Mahboobeh Razmkhah
Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
Abbas Ghaderi
Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran